About Frontida BioPharm
Frontida BioPharm is a company based in Exton (United States) founded in 2016 was acquired by Adare Pharma Solutions in December 2021. Frontida BioPharm has raised $8.35 million across 1 funding round from investors including Adare Pharma Solutions. The company has 243 employees as of December 31, 2022. Frontida BioPharm operates in a competitive market with competitors including Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
- Headquarter Exton, United States
- Employees 243 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Frontida Biopharm, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$8.35 M (USD)
in 1 rounds
-
Latest Funding Round
$8.35 M (USD), Series A
Aug 09, 2016
- Investors
-
Employee Count
243
as on Dec 31, 2022
-
Acquired by
Adare Pharma Solutions
(Dec 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Frontida BioPharm
Unlock access to complete
Funding Insights of Frontida BioPharm
Frontida BioPharm has successfully raised a total of $8.35M through 1 strategic funding round. The most recent funding activity was a Series A round of $8.35 million completed in August 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Frontida BioPharm
Frontida BioPharm has secured backing from 1 investor. Prominent investors backing the company include Adare Pharma Solutions.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CDMO manufacturing solid drugs
|
Locked | Locked | Locked |
Investor details for Frontida BioPharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Frontida BioPharm
Investment portfolio details for Frontida BioPharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Frontida BioPharm
Detailed financials for Frontida BioPharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Frontida Biopharm Comparisons
Peer comparison for Frontida BioPharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Frontida BioPharm
Frontida BioPharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Almac Group, Indoco Remedies, Concord Biotech, BDR Pharmaceuticals Internationals and Aurobindo Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated CDMO services for biopharma R&D and manufacturing are offered.
|
|
| Locked | Locked | Locked |
APIs manufacturing and formulation services are provided in therapeutic segments.
|
|
| Locked | Locked | Locked |
APIs and enzymes are manufactured through fermentation by the CDMO.
|
|
| Locked | Locked | Locked |
APIs and finished products are developed and manufactured.
|
|
| Locked | Locked | Locked |
Generic biocatalytic solutions are provided for pharmaceutical applications.
|
|
| Locked | Locked | Locked |
APIs and peptides are developed and manufactured by Asymchem.
|
Detailed competitors of Frontida BioPharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Frontida Biopharm
Complete news archive for Frontida BioPharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Frontida BioPharm
Frontida BioPharm was founded in 2016.
Frontida BioPharm is headquartered in Exton, United States. It is registered at Exton, Pennsylvania, United States.
Frontida BioPharm is a funded company, having raised a total of $8.35M across 1 funding round to date.
As of Dec 31, 2022, the latest employee count at Frontida BioPharm is 243.
Frontida Biopharm, an affiliate of Frontage Laboratories that is focussed on providing CDMO services for the manufacturing of immediate and controlled release oral solid dose products. It provides the capability to manufacture highly potent active ingredients (HPAIs), combination products and DEA schedules II V products. It has a patented Duragran granulation process which claims to enhance the drug loading and creates better engineered and cost efficient controlled release products. Along with Frontage Laboratories, the company offers Clinical Trial Materials manufacturing, serialised packaging, warehousing, and stability services.
Frontida BioPharm's top competitors include Concord Biotech, BDR Pharmaceuticals Internationals and Almac Group.
Frontida BioPharm has 1 investor. Key investors include Adare Pharma Solutions.